Bacteria deliver virulence proteins termed ‘effectors’ to counteract host innate immunity. Protein-protein interactions within the host cell ultimately subvert the generation of an inflammatory response to the infecting pathogen. Here we briefly describe a subset of T3SS effectors produced by enterohemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli (EPEC), Citrobacter rodentium, and Salmonella enterica that inhibit innate immune pathways. These effectors are interesting for structural and mechanistic reasons, as well as for their potential utility in being engineered to treat human autoimmune disorders associated with perturbations in NF-κB signaling.
CITATION STYLE
El Qaidi, S., Wu, M., Zhu, C., & Hardwidge, P. R. (2019). Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity. In Advances in Experimental Medicine and Biology (Vol. 1111, pp. 205–218). Springer. https://doi.org/10.1007/5584_2018_289
Mendeley helps you to discover research relevant for your work.